BIOLARGO, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOLARGO, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $391.00K.
- BIOLARGO, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $256.00K.
- BIOLARGO, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $15.00K, a 92.61% decline year-over-year.
- BIOLARGO, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $136.00K, a 72.47% decline year-over-year.
- BIOLARGO, INC. stock issued during period, value, new issues for fiscal 2023 was $2.15M, a 40.48% decline from fiscal 2022.
- BIOLARGO, INC. stock issued during period, value, new issues for fiscal 2022 was $3.62M, a 25.91% decline from fiscal 2021.
- BIOLARGO, INC. stock issued during period, value, new issues for fiscal 2021 was $4.88M, a 75.42% increase from fiscal 2020.
- BIOLARGO, INC. stock issued during period, value, new issues for fiscal 2020 was $2.78M, a 2126.40% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $391.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $256.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $2.03M S-1 · filed 2026-04-09 | |
| 2024-12-31 | $594.00K S-1 · filed 2026-04-09 | |
| 2024-09-30 | $15.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $136.00K 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $488.00K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $2.15M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $203.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $494.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $800.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $3.62M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $1.12M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $948.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $1.20M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $4.88M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $123.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.41M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $2.11M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $2.78M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $919.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $560.00K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $901.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $125.00K 10-K · filed 2021-03-30 | |
| 2018-12-31 | $12.72K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | $839.00K 10-K · filed 2020-03-31 |
| 2018-09-30 | $445.00K 10-Q · filed 2019-11-14 | $1.31M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $212.00K 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $168.00K 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $488.50K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $511.00K 10-K · filed 2019-03-29 |
| 2016-09-30 | $213.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $536.50K derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-06-30 | $315.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | |
| 2016-03-31 | $173.15K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$166.25K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $64.56K 10-K · filed 2016-03-30 |